Status: Recruiting
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
This study aims to investigate the association between serum biomarkers and clinical response to anti-VEGF or dexamethasone implant by assessing OCT-biomarkers in patients with diabetic macular edema, DME, and to compare these with a group of naive patients (those not previously treated for DME).
Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Vastra Gotaland RegionUpdated: Nov 21, 2025Locations: 2
Eligibility criteria
Type I or type II DM. [+1]
Prior history of any other macular disease. [+6]